Frontier Biotechnologies Inc. (SHA:688221)
China · Delayed Price · Currency is CNY 16.87
+0.45 (2.74%)
At close: Sep 30, 2026
Frontier Biotechnologies Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 393.23 | 170.34 | 248.98 | 526.66 | 550.89 | 800.85 |
Short-Term Investments | 195.59 | - | - | - | - | - |
Trading Asset Securities | 317.86 | 542.79 | 600.53 | 415.06 | 690.11 | 679.36 |
Cash & Short-Term Investments | 906.67 | 713.14 | 849.51 | 941.72 | 1,241 | 1,480 |
Cash Growth | 24.67% | -16.05% | -9.79% | -24.12% | -16.16% | -16.78% |
Accounts Receivable | 34.09 | 58.49 | 34.75 | 63.01 | 36.14 | 22.34 |
Other Receivables | 134.62 | 133.6 | 227.7 | 2.37 | 10.55 | 1.13 |
Receivables | 168.71 | 192.09 | 262.45 | 65.38 | 46.68 | 23.48 |
Inventory | 65.43 | 66.62 | 41.06 | 59 | 55.61 | 38.62 |
Prepaid Expenses | 8.5 | - | - | - | - | - |
Other Current Assets | 44.23 | 32.97 | 69.6 | 36.68 | 62.78 | 35.2 |
Total Current Assets | 1,194 | 1,005 | 1,223 | 1,103 | 1,406 | 1,578 |
Property, Plant & Equipment | 411.03 | 423.23 | 393.31 | 793.02 | 728.06 | 605.76 |
Long-Term Investments | 21.55 | 21.27 | 29.96 | - | - | - |
Other Intangible Assets | 113.3 | 127.55 | 149.32 | 229.18 | 257.22 | 258.44 |
Long-Term Deferred Charges | 1.91 | 1.44 | 2.03 | 0.94 | 2.74 | 3.12 |
Other Long-Term Assets | 4.25 | - | 14.89 | 14.21 | 16.76 | 87.8 |
Total Assets | 1,746 | 1,578 | 1,812 | 2,140 | 2,411 | 2,533 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 2.03 | 30.75 | 3.25 | 1.13 | 2.69 | 3.32 |
Accrued Expenses | 40.99 | 36.87 | 28.21 | 37.39 | 41.84 | 38.98 |
Short-Term Debt | 136.14 | 249.71 | 283.97 | 202.3 | 110.64 | 52.19 |
Current Portion of Long-Term Debt | 14.34 | 74.22 | 43.01 | 104.06 | 46 | 227.77 |
Current Portion of Leases | 0.06 | - | 0.23 | 2.4 | 4.42 | 5.09 |
Current Unearned Revenue | 40.18 | 1.82 | 2.68 | 5.83 | 0.06 | - |
Other Current Liabilities | 7.05 | 16.97 | 33.86 | 27.04 | 71.58 | 72.14 |
Total Current Liabilities | 240.8 | 410.34 | 395.2 | 380.16 | 277.23 | 399.49 |
Long-Term Debt | 268.88 | 82.86 | 79.36 | 71.42 | 117.12 | 7.5 |
Long-Term Leases | - | - | - | 0.17 | 0.45 | 0.41 |
Long-Term Unearned Revenue | 201.06 | 206.66 | 196.26 | 329.35 | 323.54 | 269.41 |
Other Long-Term Liabilities | 0.97 | 1.59 | - | 16.35 | 21.08 | 25.59 |
Total Liabilities | 711.71 | 701.44 | 670.83 | 797.44 | 739.41 | 702.41 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 374.58 | 374.58 | 374.58 | 374.58 | 374.58 | 359.76 |
Additional Paid-In Capital | 2,735 | 2,727 | 2,723 | 2,723 | 2,723 | 2,540 |
Retained Earnings | -2,076 | -2,225 | -1,956 | -1,755 | -1,426 | -1,069 |
Comprehensive Income & Other | 0.12 | 0.04 | 0.02 | 0.01 | 0.03 | -0.05 |
Total Common Equity | 1,034 | 876.87 | 1,141 | 1,343 | 1,671 | 1,830 |
Shareholders' Equity | 1,034 | 876.87 | 1,141 | 1,343 | 1,671 | 1,830 |
Total Liabilities & Equity | 1,746 | 1,578 | 1,812 | 2,140 | 2,411 | 2,533 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 419.42 | 406.79 | 406.56 | 380.35 | 278.62 | 292.96 |
Net Cash (Debt) | 487.25 | 306.35 | 442.95 | 561.37 | 962.38 | 1,187 |
Net Cash Growth | 23.80% | -30.84% | -21.09% | -41.67% | -18.94% | -32.01% |
Net Cash Per Share | 1.31 | 0.82 | 1.19 | 1.50 | 2.64 | 3.29 |
Filing Date Shares Outstanding | 374.58 | 374.58 | 374.58 | 374.58 | 374.58 | 359.76 |
Total Common Shares Outstanding | 374.58 | 374.58 | 374.58 | 374.58 | 374.58 | 359.76 |
Working Capital | 952.75 | 594.48 | 827.41 | 722.63 | 1,129 | 1,178 |
Book Value Per Share | 2.76 | 2.34 | 3.05 | 3.58 | 4.46 | 5.09 |
Tangible Book Value | 920.57 | 749.32 | 991.99 | 1,114 | 1,414 | 1,572 |
Tangible Book Value Per Share | 2.46 | 2.00 | 2.65 | 2.97 | 3.78 | 4.37 |
Buildings | 312.11 | 312.11 | 159.06 | 76.22 | 76.22 | - |
Machinery | 172 | 172.19 | 127.73 | 47.35 | 45.92 | 30.44 |
Construction In Progress | 0.38 | 0.41 | 147.74 | 695.97 | 622.9 | 582.29 |